Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicin

Single nucleotide polymorphisms (SNPs) in the multiple drug resistance protein 1 (MRP1) and P-glycoprotein 1 (MDR1) genes modulate their ability to mediate drug resistance. We therefore sought to retrospectively evaluate their influence on outcomes in relapsed and/or refractory myeloma patients trea...

Full description

Saved in:
Bibliographic Details
Main Authors: Buda, Gabriele, Ricci, Deborah, Huang, C. Chris, Favis, Reyna, Cohen, Nadine, Zhuang, Sen H., Harousseau, Jean-Luc, Sonneveld, Pieter, Bladé, Joan, Orlowski, Robert Z.
Format: Artigo
Language:Inglês
Published: Springer-Verlag 2010
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2940014/
https://ncbi.nlm.nih.gov/pubmed/20532504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-010-0992-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items